Login
Toggle navigation
Videos
Categories
Trending
BVZ Group Half-Year Financials 2019: An Interview with Fernando Lehner, Company Leader | Fernando Lehner - CEO of bvz holding ag
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Fernando Lehner is the CEO of bvz holding ag
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
CloudCall CEO says half year results show 'key metrics at the top of our scales' | Simon Cleaver, CEO, Cloudcall Group PLCCLLLF:PNK
00:10:00
Exploring Nathan Glazer's Influence: A Conversation with Professor Peter Skerry|Peter Skerry,Professor,Boston College
00:10:00
Recognizing Potential: Box CEO Aaron Levie's Vision and Leadership|Mamoon Hamid,Partner, Kleiner Perkins
00:00:00
Moritz F. Jäger,CTO of Northern Bitcoin
00:10:00
fund backing the next-rising technologies|Brian Lee, Managing Director,BAM Ventures
00:10:00
Revitalizing Education Federalism: How Centralization and Local Empowerment Are Shaping 2030's Schools
00:10:00
Enrique Escalante Addresses GCCA at Atlanta CEO Gathering | Enrique Escalante - CEO of GCC SAB de
00:10:00
Get to Know Tim Schau: Syverson Strege Team | Tim Schau - IT Support Specialist of Syverson Strege
00:10:00
founders need to know about responsible|Nikhil Sachdev,Managing Director,Insight Partners
00:10:00
Charles Murray on America's Civic Culture and Family Changes|Charles Murray
00:10:00
Understanding Active External Engagement: AXA IM for Progress Monitor - Olivier Eugene
00:10:00
Join Ajay Kochhar, CEO of Li-Cycle, as he explores the innovative field of lithium-ion battery recycling in partnership with Company (ABAT).